EQUITY (Details) - Warrant [Member] - $ / shares |
12 Months Ended | |
---|---|---|
Dec. 31, 2023 |
Dec. 31, 2022 |
|
Number Of Shares Outstanding, Beginning | 270,053 | 295,601 |
Number Of Shares Outstanding, Expired | (27,420) | (25,548) |
Number Of Shares Outstanding, Ending | 242,633 | 270,053 |
Weighted Average Exercie Price, Beginning | $ 64.16 | $ 69.45 |
Weighted Average Exercise Price, Granted | 0 | 0 |
Weighted Average Exercise Price Expired | 198.07 | (125.92) |
Weighted Average Exercise Price Exercised | 0 | 0 |
Weighted Average Exercie Price, Ending | $ 44.07 | $ 64.16 |
Weighted Average Life (years), Beginning | 2 years 18 days | 2 years 9 months 29 days |
Weighted Average Life (years), Ending | 1 year 1 month 6 days | 2 years 18 days |
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Weighted average price at which option holders acquired shares when converting their stock options into shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Details
|